BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30445463)

  • 1. A neuronal enhancer network upstream of MEF2C is compromised in patients with Rett-like characteristics.
    D'haene E; Bar-Yaacov R; Bariah I; Vantomme L; Van Loo S; Cobos FA; Verboom K; Eshel R; Alatawna R; Menten B; Birnbaum RY; Vergult S
    Hum Mol Genet; 2019 Mar; 28(5):818-827. PubMed ID: 30445463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation.
    Wang J; Zhang Q; Chen Y; Yu S; Wu X; Bao X; Wen Y
    BMC Med Genet; 2018 Oct; 19(1):191. PubMed ID: 30376817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
    Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
    Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
    Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models.
    Mohajeri K; Yadav R; D'haene E; Boone PM; Erdin S; Gao D; Moyses-Oliveira M; Bhavsar R; Currall BB; O'Keefe K; Burt ND; Lowther C; Lucente D; Salani M; Larson M; Redin C; Dudchenko O; Aiden EL; Menten B; Tai DJC; Gusella JF; Vergult S; Talkowski ME
    Am J Hum Genet; 2022 Nov; 109(11):2049-2067. PubMed ID: 36283406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β1 regulates expression of the matrix metalloproteinase 20 (Mmp20) gene through a mechanism involving the transcription factor, myocyte enhancer factor-2C, in ameloblast lineage cells.
    Gao Y; Zhang L; Xiang L; Li B; Liu X; Wang Y; Sun Y
    Eur J Oral Sci; 2014 Apr; 122(2):114-20. PubMed ID: 24495128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Regulatory Elements and Target Genes of Megakaryopoietic Transcription Factor MEF2C.
    Kong X; Ma L; Chen E; Shaw CA; Edelstein LC
    Thromb Haemost; 2019 May; 119(5):716-725. PubMed ID: 30731491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the ZEB2 regulatory landscape.
    Bar Yaacov R; Eshel R; Farhi E; Shemuluvich F; Kaplan T; Birnbaum RY
    Hum Mol Genet; 2019 May; 28(9):1487-1497. PubMed ID: 30590588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor 4 and myocyte enhancer factor 2C mutations are not common causes of Rett syndrome.
    Armani R; Archer H; Clarke A; Vasudevan P; Zweier C; Ho G; Williamson S; Cloosterman D; Yang N; Christodoulou J
    Am J Med Genet A; 2012 Apr; 158A(4):713-9. PubMed ID: 22383159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mitchell AC; Javidfar B; Pothula V; Ibi D; Shen EY; Peter CJ; Bicks LK; Fehr T; Jiang Y; Brennand KJ; Neve RL; Gonzalez-Maeso J; Akbarian S
    Mol Psychiatry; 2018 Jan; 23(1):123-132. PubMed ID: 28115742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons.
    Cosgrove D; Whitton L; Fahey L; Ó Broin P; Donohoe G; Morris DW
    Hum Mol Genet; 2021 May; 30(11):961-970. PubMed ID: 32975584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
    De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
    Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
    Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
    Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
    Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
    J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
    Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
    Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function analysis of Mef2c promoter in muscle differentiation.
    Jin W; Liu M; Peng J; Jiang S
    Biotechnol Appl Biochem; 2017 Sep; 64(5):647-656. PubMed ID: 27354201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEF2C exon α: role in gene activation and differentiation.
    Infantino V; Convertini P; Menga A; Iacobazzi V
    Gene; 2013 Dec; 531(2):355-62. PubMed ID: 24008018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Binding Protein, HuR, Regulates
    Zhou A; Shi G; Kang GJ; Xie A; Liu H; Jiang N; Liu M; Jeong EM; Dudley SC
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29678826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies.
    Lambert L; Bienvenu T; Allou L; Valduga M; Echenne B; Diebold B; Mignot C; Héron D; Roth V; Saunier A; Moustaïne A; Jonveaux P; Philippe C
    Clin Genet; 2012 Nov; 82(5):499-501. PubMed ID: 22449245
    [No Abstract]   [Full Text] [Related]  

  • 20. A neural network based model effectively predicts enhancers from clinical ATAC-seq samples.
    Thibodeau A; Uyar A; Khetan S; Stitzel ML; Ucar D
    Sci Rep; 2018 Oct; 8(1):16048. PubMed ID: 30375457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.